Amylyx Pharmaceuticals Inc RELYVRIOâ„¢ FDA Approval Call Transcript - Thomson StreetEvents

Amylyx Pharmaceuticals Inc RELYVRIOâ„¢ FDA Approval Call Transcript

Amylyx Pharmaceuticals Inc RELYVRIOâ„¢ FDA Approval Call Transcript - Thomson StreetEvents
Amylyx Pharmaceuticals Inc RELYVRIOâ„¢ FDA Approval Call Transcript
Published Sep 30, 2022
10 pages (6845 words) — Published Sep 30, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of AMLX.OQ conference call or presentation 30-Sep-22 12:00pm GMT

  
Brief Excerpt:

...Operator Good morning. My name is Rocco, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals RELYVRIO FDA approval Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Lindsey Allen, Head of Investor Relations and Communications. Please proceed. Lindsey Allen Good morning, and thank you for joining us today to discuss the FDA approval of RELYVRIO, previously known as AMX0035 in the U.S. With me on the call are co-CEOs, Josh Cohen and Justin Klee; and Margaret Olinger, Chief Commercial Officer. Chief Financial Officer, Jim Frates, will be joining us for Q&A. Before we begin, I would like to remind everyone that some of the statements that we make on this call and information presented in the slide deck include forward-looking statements that are based on our current plans and expectations, including with respect...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Amylyx Pharmaceuticals Inc
Ticker
AMLX.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Amylyx Pharmaceuticals Inc Q4 2022 Earnings Call Transcript – 2023-03-13 – US$ 54.00 – Edited Transcript of AMLX.OQ earnings conference call or presentation 13-Mar-23 8:30pm GMT

Amylyx Pharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript – 2023-02-14 – US$ 54.00 – Edited Transcript of AMLX.OQ presentation 14-Feb-23 3:00pm GMT

Amylyx Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript – 2022-11-29 – US$ 54.00 – Edited Transcript of AMLX.OQ presentation 29-Nov-22 8:05pm GMT

Amylyx Pharmaceuticals Inc Q3 2022 Earnings Call Transcript – 2022-11-10 – US$ 54.00 – Edited Transcript of AMLX.OQ earnings conference call or presentation 10-Nov-22 9:30pm GMT

Amylyx Pharmaceuticals, Inc. - Special Call Transcript – 2022-09-30 – US$ 54.00 – Edited Transcript of AMLX.OQ conference call or presentation 30-Sep-22 12:00pm GMT

Amylyx Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2022-06-09 – US$ 54.00 – Edited Transcript of AMLX.OQ shareholder or annual meeting 9-Jun-22 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Amylyx Pharmaceuticals Inc RELYVRIOâ„¢ FDA Approval Call Transcript" Sep 30, 2022. Alacra Store. Apr 23, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Amylyx-Pharmaceuticals-Inc-RELYVRIO-FDA-Approval-Call-T15349278>
  
APA:
Thomson StreetEvents. (2022). Amylyx Pharmaceuticals Inc RELYVRIOâ„¢ FDA Approval Call Transcript Sep 30, 2022. New York, NY: Alacra Store. Retrieved Apr 23, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Amylyx-Pharmaceuticals-Inc-RELYVRIO-FDA-Approval-Call-T15349278>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.